Language selection

Search

Patent 1110971 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1110971
(21) Application Number: 304330
(54) English Title: COLLAGEN SKIN DRESSING
(54) French Title: PANSEMENT AU COLLAGENE
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 18/27
  • 167/325
  • 195/61
(51) International Patent Classification (IPC):
  • A61L 15/32 (2006.01)
  • A61L 15/42 (2006.01)
  • A61L 15/44 (2006.01)
(72) Inventors :
  • MIYATA, TERUO (United States of America)
(73) Owners :
  • PIKOK INTERNATIONAL TRADING CO., LTD. (Afghanistan)
(71) Applicants :
(74) Agent: OSLER, HOSKIN & HARCOURT LLP
(74) Associate agent:
(45) Issued: 1981-10-20
(22) Filed Date: 1978-05-29
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
805,003 United States of America 1977-06-09

Abstracts

English Abstract



ABSTRACT OF THE DISCLOSURE

Skin or wound dressings are prepared in gel or film
form from collagen and/or chemically modified collagen.


Claims

Note: Claims are shown in the official language in which they were submitted.


The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:-


1. A process for the preparation of porous collagen
skin dressing which comprises forming a collagen gel, ex-
truding the collagen gel into a coagulation bath, forming a
sheet of collagen from the extruded gel, cross-linking the
extruded collagen, and subjecting the cross-linked sheet to
freeze-drying.


2. The process of claim 1 in which the cross-linking
is carried out by tanning with glutaraldehyde.


3. The process of claim 1, which comprises the steps
of:
a) treating a source of collagen with a proteolytic
enzyme to form a telopeptide-poor, monomolecularly disper-
sed atelocollagen extract,
b) precipitating atelocollagen from the extract,
c) purifying the precipitated atelocollagen by redis-
solving and reprecipitation,
d) converting the extracted, purified atelocollagen
to a gel,
e) extruding the atelocollagen gel through a circular
extrusion nozzle in a coagulation bath,
f) recovering atelocollagen in tubular form from the
coagulation bath,
g) slitting the tubular collagen longitudinally to
form a collagen sheet therefrom,
h) cross-linking the longitudinal sheet, and

i) subjecting the cross-linked sheet to freeze-drying.


4. The process of claim 3 in which the cross-linking
is carried out by tanning with glutaraldehyde.



5. The process of claim 1 wherein there is included
at least one material selected from antibiotics and bacte-
ricidal agents.


6. The process of claim 2 wherein there is included
at least one material selected from antibiotics and bacte-
ricidal agents.


7. The process of claim 3 wherein there is included
at least one material selected from antibiotics and bacte-
ricidal agents.


8. The process of claim 4 wherein there is included
at least one material selected from antibiotics and bacte-
ricidal agents.


9. A process for the preparation of collagen skin
dressing of limited porosity which comprises forming a
collagen gel, extruding the collagen gel into a coagulation
bath, forming a sheet of collagen from the extruded gel,
cross-linking the extruded collagen, partially air-drying
the cross-linked sheet, and subjecting the partially air-
dried sheet to freeze-drying.


10. The process of claim 9 in which the cross-linking
is carried out by tanning with glutaraldehyde.



11. The process of claim 9 for the preparation of a
collagen skin dressing in sheet form whose upper and lower
surfaces possess differing porosity characteristics which
comprises the steps of:
a) treating a source of collagen with a proteolytic
enzyme to form a telopeptide-poor, monomolecularly disper-
sed atelocollagen extract,
b) precipitating atelocollagen from the extract,




c) purifying the precipitated atelocollagen by redis-
solving and reprecipitation,
d) converting the extracted, purified atelocollagen to
a gel,
e) extruding the atelocollagen gel through a circular
extrusion nozzle in a coagulation bath,
f) recovering atelocollagen in tubular form from the
coagulation bath,
g) slitting the tubular collagen longitudinally to
form a collagen sheet therefrom,
h) cross-linking the longitudinal sheet,
i) partially air-drying the cross-linked sheet, and
j) freeze-drying the partially air-dried sheet where-
by the upper surface of said sheet becomes more concentra-
ted in ateloeollagen content than the lower surface thereof.


12. The process of claim 11 in which the cross-link-
ing is carried out by tanning with glutaraldehyde.


13. The process of claim 9 wherein there is included
at least one material selected from antibiotics and bacte-
ricidal agents.


14. The process of claim 10 wherein there is included
at least one material selected from antibiotics and bacte-
ricidal agents.


15. The process of claim 11 wherein there is included
at least one material selected from antibiotics and bacte-

ricidal agents.


16. The process of claim 12 wherein there is included
at least one material selected from antibiotics and bacte-
ricidal agents.


17. A skin dressing of petroleum jelly consistency
11

comprising enzyme-solubilized acylated atelocollagen gel and
at least one substance selected from antibiotics and bacte-
ricides.


18. A skin dressing according to claim 17 in which the
acylated atelocollagen is succinylated atelocollagen.


19. A skin dressing of petroleum jelly consistency
comprising solubilized succinylated collagen gel and at
least one material selected from bactericidal agents and
antibiotics.


20. A method for the preparation of a collagen skin
dressing in gel form which comprises the steps of:
a) treating a source of collagen with a proteolytic
enzyme to form a telopeptide-poor, monomolecularly disper-
sed atelocollagen extract,
b) precipitating atelocollagen from the extract,
c) reacting an aqueous dispersion of the atelocollagen
extract with an acylating agent,
d) separating acylated atelocollagen from the reaction
mixture, and
e) converting the acylated atelocollagen to a gel of
petroleum jelly consistency.


21. The method according to claim 20 in which the
acylating agent is succinic anhydride.



22. The method according to claim 20 in which the
acylated atelocollagen is purified by solution and re-pre-
cipitation prior to its conversion to a gel.


23. The method according to claim 21 in which the
acylated atelocollagen is purified by solution and re-pre-
cipitation prior to its conversion to a gel.


12

24. The method according to claim 20 in which there is
incorporated into the gel at least one substance selected
from antibiotics and bactericides.


25. The method according to claim 21 in which there is
incorporated into the gel at least one substance selected
from antibiotics and bactericides.


26. The method according to claim 22 in which there is
incorporated into the gel at least one substance selected
from antibiotics and bactericides.


27. The method according to claim 23 in which there is
incorporated into the gel at least one substance selected
from antibiotics and bactericides.

13





Description

Note: Descriptions are shown in the official language in which they were submitted.


7~
This invention relates to skin dressings consisting of
collagen or chemically modified collagen in gel form, in porous
sheet form or in semiporous film type form. The invention also
relates to the production of such skin dressings by preparation
of sterile succinylated collagen gel, and by preparation of
collagen porous sheet made by successive processes of
extrusion of collagen gel into coagulation bath, tanning with
glutaraldehyde, and/or partial air-drying followed by freeze-
drying. Bactericidal agents or antibiotics may be impregnated
into the gel or sheet-type dressing.
A number of investigators including the present inventors
~; have suggested the use of collagen material as a skin, burn or
wound dressing. The feature of this invention, however,
; consists in the form of the collagen dressing and in the method
of producing such desired types.
The National Fire Protection Association reported in
1962 that approximately l,800~000 persons sustain burns yearly
and occupy over ll,000 hospital beds per day. There is a great
need for a readily available, easily stored and temporary
substitute for human skin for the effective treatment of
thermal burns and other forms of skin loss. It is common
practice to cover skin loss area with split-thickness autografts,
homografts and heterografts. Such treatments protect against
` infection, the loss of protein, fluid and electrolytes from
exposed tissue. These treatments, however have the following
drawbacks. Grafts are difficult to obtain, and to store for
any prolonged period of time and also are quite expensive.
These difficulties could be reduced by the development of
artificial skin dressings which are inexpensive and readily
available to use.



-- 1 --
.

:

37~
Collagen is a major protein of connect tissue such as
skin, cornea, etc. and can be solubilized, separated and
purified by the treatment with proteolytic enzymes (other than
collagenase), e.g., proctase, pepsin, trypsin and pronase.
Solubilized collagen is telopeptides-poor, relatively inexpensive
and ideal as a material for development into a skin wound
dressing.
Solubilized collagen has many NH2 and COOH groups in its
structure, and chemical modifications of the molecule can be
readily made, e.g., all or some of the amino groups may be
acylated by reaction with a mixture of acetic anhydride and
acetic acid. Similarly, succinic anhydride reacts with
collagen replacing amino groups by carboxyl groups. The
carboxyl groups contained in the molecule are susceptible to
esterification by the standard reaction with acidified alochol,
e.g., reaction with anhydrous methanol acidified with HCl. In
the above reactions the net isoelectric point of collagen can
- be controlled, either negative or positive, or completely
neutralized.
All known types of collagen and chemically modified
collagen may be employed in the practice of this invention
e.g., native, denatured collagen (neutral isoelectric point);
esterified collagen (alkaline isoelectric point) and modified
amino-group forms e.g., anhydride derivatives (acidic lsoelectric
point). In the preparation of gel type dressings of this
invention the use of anhydride derivatives (acidic isoelectric
point) e.g., succinic anhydride derivatives of collagen are
preferred.
Gel Type
The gel type skin dressings of this invention are
especially suitable for application to irregular body surfaces

- 2 -

97~

e.g., areas of the joints, elbows, knees, etc. The gel dressing
is preferably used in the form of a viscous paste of petroleum
jelly consistency and contains 1 - 10%, preferably 2 - 5~ of
collagen.
In the preparation of the collagen gel, skin or hide is
solubilized in an enzyme solution at acidic pH. The resulting
gel is a viscous material which is recovered by filtering, e.g.,
through cheese cloth and/or a millipore filter. The viscous
solution is made alkaline by addition of caustic to a pH of
about 10. At this stage the material is permitted to stand in
order to inactivate any remaining enzyme. The material is
thereafter neutralized, the collagen collected by centrifuge
and washed with water. A second purification step follows,
namely, redissolving in aqueous acid (pH 2.0 - 5.0), reprecipi-
tation by neutralization to a pH of 6 to 7, and purification to
remove acid by dialysis against water. The neutral gel is
recovered and at this stage antibiotics or bactericides or
both may be added before storage of the gel material.
Collagen material used in the preparation of gel is
preferably not a multimer and, therefore, the material is not
- subjected to tanning during its preparation.
Succinylated collagen was preferably used for making
viscous gel skin dressing since it can be redissolved in water
at physiologic pH (6.8 - 7.4) without requiring dialysis against
water to remove acid during its preparation. Collagen concentra-
tion of gel skin dressing was between 0.5% to 7~ and into it
was incorporated the following bactericidal agents: Silver
nitrate solution (0.5 g/100 ml) or silver lactate solution
(9.5 g/100 ml) 25 mg/ml Lincomycin, 5 mg/ml Amphotericin B
and 25 mg/ml Gentamicin, or one or more thereof.




-- 3




, .

g~l

Pourous Sheet Type
Another type of collagen skin dressing (porous sheet)
was prepared as follows: Solubilized collagen gel (pH 2.0 -
3.5, collagen concentration 1% - 10%) was extruded from a
tubular nozzle into coagulation bath (saturated NaCl).
Coagulated tubular collagen was cut longitudinally to obtain
sheet and tanned with 1 - 5~ glutaraldehyde in saturated NaCl
containing 0.05 M Na2HPO4 for 0.5 - 3.0 hours. Tanned collagen
sheet was washed with water repeatedly, then freeze-dried on
methylmethacrylate plate. To produce a semi-porous, film type
sheet in which the upper surface of the sheet is more concentrated
in collagen (resulting in an upper film type surface) and in
which the lower surface of the sheet is less concentrated in
collagen (i.e. more porous) the sheet is sub~ect to partial
air-drying prior to freeze-drying. Collagen sheet was sterilized
by ethylene oxide gas and soaked in a typical base solution
containing one or more bactericidal agents, such as silver
nitrate (0.5 g/100 ml), or silver lactate (0.5 g/100 ml), or
lactated Ringer's solution containing 25 mg/ml Gentamicin,
25 mg/ml Lincomycin, 25 mg/ml Colistimethate, 25 mg/ml Kanamycin,
and 5 mg/ml Amphotericin B; or lactated Ringer's solution
containing 25 mg/ml Lincomycin, 5 mg/ml Amphotericin B, and
25 mg/ml Gentamicin.
An effective skin dressing should have the following
properties:
1. good adherence to wound surface,
2. prevention of loss of protein, fluid and electrolytes,
3. prevention of infection,
4. reduction of pain,
5. no stimulation of local tissue response, etc.
Collagen skin dressings described here satisfy the above


- a _

' :

g71

properties and are easy to use and less expensive. Gel skin
dressing is especially suitable for application to irregular
surfaces e.g., joint surfaces. Viscous gel-like paste and
gels of petroleum jelly consistency show excellent adherence
to wound surfaces. Porous sheet, and semi-porous film type
dressings also adhere firmly to the wound. Extensive cell
ingrowth into the porous collagen sheet was observed. All
skin dressings indicated effective protection against infection
and good wound healing.
The present invention may be further understood from the
following examples:
EXAMPLE 1
-
Fresh calfskin (about 5 kg) was dehaired, cleaned by
shaving and cut into small pieces. The skin was washed
repeatedly with 10% NaCl containing a 0.2~ sodium azide
bactericide and with sterilized water. The skin was solubilized
in 10 liters of water (pH 2.5 HCl) containing 30 mg/ml
Gentamicin by addition of 1 g. of pepsin (approximate ratio of
enzyme to colla~en was 1/400) at 20C for 4 days with intermittent
stirring. The resulting viscous solubilized collagen was
filtered through cheesecloth, its pH raised to 10 by NaOH and
allowed to stand for 24 hours at 20C to inactivate the pepsin.
The pH of collagen was then adjusted to 7-8 (HCl) and collagen
precipitate was collected by centrifuging and washed with
sterilized water. The washed precipitate was redissolved in
acidic solution and reprecipitated at pH 7-8 for further
purification.
Succinylation of solubilized collagen was preformed as
follows: Ten grams (dry basis) of solubilized collagen
precipitate was resuspended in 4 liters of water and its pH

adjusted to 9.0 by NaOH. Acetone solution (100 ml) containing


97~

2.0 g of succinic anhydride was gradually added to the collagen
suspension. During the addition of succinic anhydride the pH
of collagen suspension was maintained at about 9.0 by NaOH
solution. Succinylated collagen was precipitated by acidification
to about pH 4.2, washed with water and freeze-dried. This
freeze-dried collagen (sponge-like in form) was sterilized to
remove micro-organisms. Five grams of the sterilized collagen
sponge was dissolved in acidified water. Upon addition of NaOH
to a pH of abo~t 7.4 the collagen emerges in a highly viscous
form. It was preserved by addition of silver nitrate (0.5%
solution). This gel skin dressing was excellent in adhesion
to the wound, in wound healing, and in protection against
infection.
EXAMPLE 2
Succinylated solubilized collagen was prepared by the
method described in Example 1. Sterilized succinylated collagen
(10 g) was treated in the same manner as in Example 1 but
preserved by Silver Lactate (0.5% solution). This gel skin
dressing again displayed excellent properties as above.
EXAMPLE 3
_ .
Sterilized succinylated collagen was prepared by the
method described in Example 1 and treated in the same manner as
in Example 1 but was preserved in sterile lactated Ringer's
solution (0.6~ NaCl, 0.31% sodium lactate, 0.03% potassium
chloride, 0.02% calcium chloride, pH adjusted to 7.4) containing
the following antibiotics: 25 mg/ml Lincomycin, 5 mg/ml Ampho-
tericin B, and 25 mg/ml Gentamicin. This gel skin dressing once
again displayed excellent properties. -,
EXAMPLE 4
Solubilized collagen (not succinylated) was prepared by
the method described in Example 1. The collagen was dissolved
in dilute HCL solution (final pH 2.5, collagen concentration
.~
-- 6

971

was 3~) and deairated under vacuum. Collagen acidic gel was
extruded into a coagulation bath (saturated NaCl) through an
appropriate nozzle. Coagulated tubing was recovered and cut
longitudinally to make it into sheets and tanned with 3%
glutaraldehyde in saturated NaCl containing 0.05 M Na2HPO4
for one hour. After repeated washing with water, collagen
sheet was freeze-dried on a plate of methylmethacrylate.
Freeze-dried sheets (10 cm x 10 cm) were sterilized by treatment
with ethylene oxide gas and preserved by soaking in 0.5~ silver
nitrate solution. Final thickness of the sheet was 3 mm. This
skin dressing was excellent in the adhesion to the wound, in
protection against fluid 105s and infection, and in wound
healing.
EXAMPLE 5
Collagen sheet was prepared by extrusion, tanning and
washing by the method described in Example 4, except using 5%
acidic collagen gel. Washed collagen sheet was then partially
air-dried on a plate of methylmethacrylate until the thickness
of the sheet became half of the original. This partial drying
reduces the porosity (collagen concentration higher) of the
upper surface of the sheet. It was then freeze-dried to render
the lower surface porous (collagen concentration lower), and
sterilized with ethylene oxide gas. Sterilized sheet was
preserved in sterilie 0.5~ silver lactate solution pH 7.4). The
final thickness of the sheet was 2 mm. This skin dressing had
finer porosity and greater strength than the sheet of Example 4.
It was excellent in protection of protein, fluid and electrolytes
loss, in protection against infection and in wound healing.
EXAMPLE 6
Sterile, freeze-dried collagen sheet was prepared by the
method described in Example 4, except that the collagen concen-

~ 71
tration was 5%. The sheet was preserved by soaking in sterile
lactated Ringer's solution (pH adjusted to 7.4) containing
the following antibiotics: 25 mg/ml Gentamicin, 25 mg/ml
Lincomycin, 25 mg/ml Colistimethate, 25 mg/ml Kanamycin and
S mg/ml Amphotericin B. The final thickness of the sheet was
4 mm. This sheet likewise displayed excellent skin dressing
properties.





Representative Drawing

Sorry, the representative drawing for patent document number 1110971 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1981-10-20
(22) Filed 1978-05-29
(45) Issued 1981-10-20
Expired 1998-10-20

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1978-05-29
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
PIKOK INTERNATIONAL TRADING CO., LTD.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1994-03-24 1 8
Claims 1994-03-24 5 154
Abstract 1994-03-24 1 8
Cover Page 1994-03-24 1 13
Description 1994-03-24 8 316